Haifeng Xu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Peking Union Medical College Hospital, Peking University Cancer Hospital, Ningxia Medical University · ORCID：0000-0002-6976-1129

发表论文 85 篇 · 总被引 1068 次 · h-index 17

代表论文

• Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis (2021 · Redox Biology · 被引 335)
• Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis (2023 · Redox Biology · 被引 109)
• Intermittent fasting and immunomodulatory effects: A systematic review (2023 · Frontiers in Nutrition · 被引 29)
• Exploring Advanced Therapies for Primary Biliary Cholangitis: Insights from the Gut Microbiota–Bile Acid–Immunity Network (2024 · International Journal of Molecular Sciences · 被引 23)
• Chronic kidney disease: prevalence and association with handgrip strength in a cross-sectional study (2021 · BMC Nephrology · 被引 21)
• Development of a novel autophagy-related gene model for gastric cancer prognostic prediction (2022 · Frontiers in Oncology · 被引 20)